Style | Citing Format |
---|---|
MLA | Hosami F, et al.. "The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects." Biomedicine and Pharmacotherapy, vol. 144, no. , 2021, pp. -. |
APA | Hosami F, Ghadimkhah MH, Salimi V, Ghorbanhosseini SS, Tavakoliyaraki M (2021). The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects. Biomedicine and Pharmacotherapy, 144(), -. |
Chicago | Hosami F, Ghadimkhah MH, Salimi V, Ghorbanhosseini SS, Tavakoliyaraki M. "The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects." Biomedicine and Pharmacotherapy 144, no. (2021): -. |
Harvard | Hosami F et al. (2021) 'The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects', Biomedicine and Pharmacotherapy, 144(), pp. -. |
Vancouver | Hosami F, Ghadimkhah MH, Salimi V, Ghorbanhosseini SS, Tavakoliyaraki M. The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects. Biomedicine and Pharmacotherapy. 2021;144():-. |
BibTex | @article{ author = {Hosami F and Ghadimkhah MH and Salimi V and Ghorbanhosseini SS and Tavakoliyaraki M}, title = {The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects}, journal = {Biomedicine and Pharmacotherapy}, volume = {144}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Hosami F AU - Ghadimkhah MH AU - Salimi V AU - Ghorbanhosseini SS AU - Tavakoliyaraki M TI - The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects JO - Biomedicine and Pharmacotherapy VL - 144 IS - SP - EP - PY - 2021 ER - |